琥珀酸美托洛尔联合曲美他嗪治疗冠心病心力衰竭患者的临床效果观察

Clinical Effect Observation of Metoprolol Succinate Combined with Trimetazidine in Treatment of Coronary Heart Disease Patients with Heart Failure

目的 分析冠心病心力衰竭患者采用琥珀酸美托洛尔联合曲美他嗪的治疗疗效。方法 选取2020年1—12月本院收治的66例冠心病心力衰竭患者加入研究,并按照随机数字表法分为对照组和观察组,每组33例。两组均行常规治疗,对照组采用琥珀酸美托洛尔治疗,观察组采用琥珀酸美托洛尔联合曲美他嗪治疗,观察治疗效果。结果 经治疗,观察组患者的心率、血压水平、心功能、凝血功能、炎症因子均得到明显改善(P<0.05)。结论 冠心病心力衰竭的治疗中应用琥珀酸美托洛尔联合曲美他嗪,能够改善患者身体各项指标。

Objective To analyze curative effect of metoprolol succinate combined with trimetazidine for patients with coronary heart disease and heart failure.Methods The paper chose 66patients with coronary heart disease and heart failure in our hospital from January 2020 to December 2020 for study,treated with routine treatment,divided them into control group(treated with metoprolol succinate) and observation group(with metoprolol succinate combined with trimetazidine)randomly,33 cases in each group.Curative effect was observed.Results After treatment,heart rate,blood pressure level,heart function,coagulation function,and inflammatory factors of observation group were significantly higher than control group(P<0.05).Conclusion Metoprolol succinate combined with trimetazidine can improve various physical indicators of patients with coronary heart disease and heart failure.